11-Nov-2004 | business & finance
Cellomics and BD Sign License Agreement to Further Expand Availability of High Content Screening
Cellomics, Inc., the creator of High Content Screening (HCS), and global medical technology company BD (Becton, Dickinson and Company), through its BD ...